These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2557726

  • 1. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P.
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [Abstract] [Full Text] [Related]

  • 2. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 3. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM, Pernow J, Franco-Cereceda A, Rudehill A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenalin and noradrenaline in the pithed rat.
    Dahlöf P, Persson K, Lundberg JM, Dahlöf C.
    Acta Physiol Scand; 1988 Jan; 132(1):51-7. PubMed ID: 2851918
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J, Saria A, Lundberg JM.
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [Abstract] [Full Text] [Related]

  • 6. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS.
    Acta Physiol Scand Suppl; 1989 Feb; 581():1-63. PubMed ID: 2568728
    [Abstract] [Full Text] [Related]

  • 7. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE, Lundberg JN, Weitzberg E.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y.
    Westfall TC, Martin J, Chen XL, Ciarleglio A, Carpentier S, Henderson K, Knuepfer M, Beinfeld M, Naes L.
    Synapse; 1988 Feb; 2(3):299-307. PubMed ID: 2850631
    [Abstract] [Full Text] [Related]

  • 9. Alpha- and beta-adrenoceptor-mediated effects on nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea pig.
    Dahlöf P, Tarizzo VI, Lundberg JM, Dahlöf C.
    J Auton Nerv Syst; 1991 Sep; 35(3):199-210. PubMed ID: 1744378
    [Abstract] [Full Text] [Related]

  • 10. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
    Kawasaki H, Cline WH, Su C.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):23-32. PubMed ID: 6149303
    [Abstract] [Full Text] [Related]

  • 11. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
    Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC.
    Cardiovasc Res; 2005 May 01; 66(2):345-52. PubMed ID: 15820203
    [Abstract] [Full Text] [Related]

  • 12. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS, Stjärne P, Anggärd A, Lundberg JM.
    Acta Physiol Scand; 1989 Jan 01; 135(1):17-28. PubMed ID: 2911948
    [Abstract] [Full Text] [Related]

  • 13. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T.
    Acta Physiol Scand Suppl; 1987 Jan 01; 560():1-38. PubMed ID: 2884804
    [Abstract] [Full Text] [Related]

  • 14. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV, Steiner M, Huidobro-Toro JP.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):691-8. PubMed ID: 9262332
    [Abstract] [Full Text] [Related]

  • 15. Defective modulation of noradrenergic neurotransmission by exogenous prostaglandins in aging spontaneously hypertensive rats.
    Jackson EK, Herzer WA, Lawson JA.
    J Pharmacol Exp Ther; 1989 Dec 01; 251(3):858-69. PubMed ID: 2557420
    [Abstract] [Full Text] [Related]

  • 16. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J, Kahan T, Hjemdahl P, Lundberg JM.
    Acta Physiol Scand; 1988 Jan 01; 132(1):43-50. PubMed ID: 2906210
    [Abstract] [Full Text] [Related]

  • 17. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J, Lundberg JM.
    Acta Physiol Scand; 1989 Aug 01; 136(4):507-17. PubMed ID: 2571235
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F, Argiolas L, Ruvolo G, del Basso P.
    Br J Pharmacol; 1998 May 01; 124(1):101-10. PubMed ID: 9630349
    [Abstract] [Full Text] [Related]

  • 19. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A.
    Acta Physiol Scand Suppl; 1994 May 01; 622():1-74. PubMed ID: 7524267
    [Abstract] [Full Text] [Related]

  • 20. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
    Dietrich P, Moleda L, Kees F, Müller M, Straub RH, Hellerbrand C, Wiest R.
    J Hepatol; 2013 Feb 01; 58(2):254-61. PubMed ID: 23041305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.